# Celula

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/celula

- Industry: Healthcare
- Headquarters: San Diego, US
- Website: www.celula-inc.com
- Total disclosed funding: $23M
- Latest round: Series C (Dec 16, 2013)
- Investors on record: 3

## About

Celula is a healthcare technology company focused on improving diagnostic accuracy through advanced systems. Their flagship product enhances the reliability and efficiency of diagnostic processes in clinical laboratories and hospitals.Founded in 2005 and headquartered in San Diego, US, Celula specializes in integrated diagnostic solutions. The company has secured a total of USD 8.36 mn across several funding rounds, with its most recent financing being a Venture Debt round of USD 10.00 mn from Oxford Finance Corporation in April 2015. Celula has completed 4 deals to date, reflecting its active engagement in the healthcare technology space.Celula specializes in integrated diagnostic accuracy, focusing on enhancing the reliability and efficacy of diagnostic processes in various healthcare settings. Their core product, the Integrated Diagnostic Accuracy (IDA) system, is designed to streamline diagnostic workflows by providing precise data and analytics, ultimately improving patient outcomes. The IDA system is used primarily in clinical laboratories and hospitals, enabling healthcare professionals to make informed decisions based on accurate and timely test results. Celula’s client base includes healthcare institutions and diagnostic laboratories across North America and select markets in Europe, addressing the challenges of diagnostic errors and inefficiencies that can adversely affect patient care.Celula’s revenue model is structured around direct sales to healthcare institutions and ongoing partnerships with diagnostic laboratories. The company implements a subscription-based pricing strategy that allows clients to access their IDA system and associated services on a recurring basis. This approach ensures a steady revenue stream while fostering long-term relationships with clients, who benefit from continuous updates and support. Tailored pricing plans accommodate the specific needs of various healthcare providers, facilitating scalable solutions for both large hospital networks and smaller diagnostic facilities.Celula aims to expand its product offerings and market reach in the coming years. Following the recent USD 10 mn funding round in April 2015, the company plans to enhance its Integrated Diagnostic Accuracy (IDA) system with new features aimed at improving user experience and diagnostic precision. Additionally, Celula is targeting expansion into select European markets by 2016, aiming to establish partnerships with local healthcare providers to increase its footprint in the international healthcare landscape.

## Funding rounds

- Series C, Dec 16, 2013, $8.4M — Versant Ventures
- Series B, May 19, 2010, $15M — Enterprise Partners Venture Capital, Versant Ventures, Skyline Ventures

## Investors

- Enterprise Partners Venture Capital (https://capitalatlas.ai/funds/enterprise-partners-venture-capital) — Series B
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series C
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series B